Millennium Pharmacon (Indonesia) Buy Hold or Sell Recommendation
| SDPC Stock | IDR 125.00 4.00 3.10% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Millennium Pharmacon International is 'Sell'. The recommendation algorithm takes into account all of Millennium Pharmacon's available fundamental, technical, and predictive indicators you will find on this site.
Check out Millennium Pharmacon Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Millennium and provide practical buy, sell, or hold advice based on investors' constraints. Millennium Pharmacon International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Millennium |
Execute Millennium Pharmacon Buy or Sell Advice
The Millennium recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Millennium Pharmacon International. Macroaxis does not own or have any residual interests in Millennium Pharmacon International or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Millennium Pharmacon's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Millennium Pharmacon Trading Alerts and Improvement Suggestions
| Millennium Pharmacon generated a negative expected return over the last 90 days | |
| Millennium Pharmacon has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Millennium Pharmacon International has accumulated about 43.62 B in cash with (18.18 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 34.24. | |
| Roughly 88.0% of the company outstanding shares are owned by corporate insiders |
Millennium Pharmacon Returns Distribution Density
The distribution of Millennium Pharmacon's historical returns is an attempt to chart the uncertainty of Millennium Pharmacon's future price movements. The chart of the probability distribution of Millennium Pharmacon daily returns describes the distribution of returns around its average expected value. We use Millennium Pharmacon International price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Millennium Pharmacon returns is essential to provide solid investment advice for Millennium Pharmacon.
| Mean Return | -0.12 | Value At Risk | -2.17 | Potential Upside | 1.55 | Standard Deviation | 1.21 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Millennium Pharmacon historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Millennium Pharmacon Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Millennium Pharmacon or Health Care Providers & Services sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Millennium Pharmacon's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Millennium stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.14 | |
β | Beta against Dow Jones | -0.06 | |
σ | Overall volatility | 1.20 | |
Ir | Information ratio | -0.02 |
Millennium Pharmacon Volatility Alert
Millennium Pharmacon International exhibits very low volatility with skewness of 0.01 and kurtosis of 1.52. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Millennium Pharmacon's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Millennium Pharmacon's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Millennium Pharmacon Fundamentals Vs Peers
Comparing Millennium Pharmacon's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Millennium Pharmacon's direct or indirect competition across all of the common fundamentals between Millennium Pharmacon and the related equities. This way, we can detect undervalued stocks with similar characteristics as Millennium Pharmacon or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Millennium Pharmacon's fundamental indicators could also be used in its relative valuation, which is a method of valuing Millennium Pharmacon by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Millennium Pharmacon to competition |
| Fundamentals | Millennium Pharmacon | Peer Average |
| Return On Equity | 0.0938 | -0.31 |
| Return On Asset | 0.0342 | -0.14 |
| Profit Margin | 0.01 % | (1.27) % |
| Operating Margin | 0.02 % | (5.51) % |
| Current Valuation | 828.27 B | 16.62 B |
| Shares Outstanding | 1.27 B | 571.82 M |
| Shares Owned By Insiders | 87.94 % | 10.09 % |
| Shares Owned By Institutions | 3.35 % | 39.21 % |
| Price To Earning | 9.31 X | 28.72 X |
| Price To Book | 1.16 X | 9.51 X |
| Price To Sales | 0.10 X | 11.42 X |
| Revenue | 2.99 T | 9.43 B |
| Gross Profit | 237.04 B | 27.38 B |
| EBITDA | 73.6 B | 3.9 B |
| Net Income | 9.57 B | 570.98 M |
| Cash And Equivalents | 43.62 B | 2.7 B |
| Cash Per Share | 34.24 X | 5.01 X |
| Total Debt | 1.8 B | 5.32 B |
| Debt To Equity | 257.80 % | 48.70 % |
| Current Ratio | 1.15 X | 2.16 X |
| Book Value Per Share | 202.66 X | 1.93 K |
| Cash Flow From Operations | (18.18 B) | 971.22 M |
| Earnings Per Share | 19.19 X | 3.12 X |
| Number Of Employees | 1.09 K | 18.84 K |
| Beta | 0.75 | -0.15 |
| Market Capitalization | 440.8 B | 19.03 B |
| Total Asset | 1.21 T | 29.47 B |
| Annual Yield | 0 % | |
| Net Asset | 1.21 T | |
| Last Dividend Paid | 1.0 |
Millennium Pharmacon Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Millennium . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Millennium Pharmacon Buy or Sell Advice
When is the right time to buy or sell Millennium Pharmacon International? Buying financial instruments such as Millennium Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Millennium Pharmacon in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Health Management Thematic Idea Now
Health Management
Major hospitals and healthcare providers. The Health Management theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Health Management Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Millennium Stock
Millennium Pharmacon financial ratios help investors to determine whether Millennium Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Millennium with respect to the benefits of owning Millennium Pharmacon security.